Trial site
HonorHealth Research Institute
- 32running trials
- 23closed trials
The trials here
What the 56 trials at this site are about, from their registry records.
- Conditions
- Pancreatic cancer16 trials
- Lung cancer15 trials
- Colorectal cancer10 trials
- Melanoma10 trials
- Ovarian cancer8 trials
- Bladder cancer6 trials
- Endometrial cancer5 trials
- Head and neck cancer5 trials
- Kidney cancer5 trials
- Liver and biliary tract cancer5 trials
- Prostate cancer5 trials
- Gastric and oesophageal cancer4 trials
- and 26 more
- Phase
- Phase 119 trials
- Phase 215 trials
- Phase 1/28 trials
- Phase 36 trials
- Status
- Recruiting20 trials
- Completed16 trials
- Active, not recruiting10 trials
- Terminated4 trials
- Withdrawn3 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Suspended1 trial
- Lead sponsor
- HonorHealth Research Institute7 trials
- Revolution Medicines, Inc.3 trials
- Agenus Inc.2 trials
- Bayer2 trials
- Cogent Biosciences, Inc.2 trials
- and 39 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Recruiting
Recruiting
Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Recruiting
Recruiting
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Recruiting
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Recruiting
Active, not recruiting
Recruiting
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Recruiting
Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Recruiting
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Recruiting
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Recruiting
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
Active, not recruiting
(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
Active, not recruiting
A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer
Active, not recruiting
The AUDACITY Study (AllUrion Device in Adults With Clinical ObesITY)
Recruiting
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Active, not recruiting
Recruiting
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Enrolling by invitation
Post Market Clinical Follow-Up Study for PROFEMUR® Preserve Classic Femoral Stem
Active, not recruiting
Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial
Active, not recruiting
Active, not recruiting
Active, not recruiting
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer
Active, not recruiting
Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer8 recruiting
- Pancreatic cancer6 recruiting
- Colorectal cancer4 recruiting
- Melanoma3 recruiting
- Prostate cancer3 recruiting
- Head and neck cancer2 recruiting
- Mesothelioma2 recruiting
- Triple-negative breast cancer2 recruiting
- Alzheimer disease1 recruiting
- Bladder cancer1 recruiting
- Brain metastases1 recruiting
- Coronary artery disease1 recruiting
- Cystic fibrosis1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Kidney cancer1 recruiting
- Lewy body dementia1 recruiting
- Mild cognitive impairment1 recruiting
- Osteoarthritis1 recruiting
- Osteonecrosis (avascular necrosis)1 recruiting
- Ovarian cancer1 recruiting
- Sarcoma1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Recruiting
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
Completed
Completed
Terminated
Completed
Completed
Withdrawn
Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas
Completed
Withdrawn
Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers
Completed
Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer
Completed
A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors
Completed
Completed
Completed
TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers
Completed
Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
Terminated
Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.
Completed
Terminated
Recruiting
Completed
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
Completed
Completed
Pre-operative Treatment for Patients With Untreated Pancreatic Cancer
Terminated
Site data: ClinicalTrials.govUpdated 18 Nov 2026